EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells

Annalucia Serafino iD, Ewa Krystyna Krasnowska iD, Sabrina Romanò iD, Alex De Gregorio iD, Marisa Colone iD, Maria Luisa Dupuis iD, Massimo Bonucci iD, Giampietro Ravagnan iD, Annarita Stringaro iD, Maria Pia Fuggetta

International Journal of Molecular Sciences · 30.09.2024 · 25 (19) · 10572

DOI: 10.3390/ijms251910572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2024. Verfasst von Annalucia Serafino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Pharmacology, National Research Council of Italy (CNR), 00133 Rome, Italy. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Glucosides, Curcumin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ShermanTree Nutraceuticals and MIMIT (Ministry of Enterprise and Made in Italy), Project Invitalia Brevetti+, Invitalia Brevetti+, European Union—Next Generation EU, within the PNRR project “Rome Technopole—Innovation Ecosystem”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBL) is one of the more malignant primary brain tumors; it is currently treated by a multimodality strategy including surgery, and radio- and chemotherapy, mainly consisting of temozolomide (TMZ)-based chemotherapy. Tumor relapse often occurs due to the establishment of TMZ resistance, with a patient median survival time of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaGlucosidesCurcuminDrug SynergismStilbenesApoptosisHumansCell Line, TumorCell SurvivalCell ProliferationAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsAutophagyCell Cycle

Stichwörter der Autor:innen

chemoresistancecurcuminglioblastomapolydatintemozolomide

Substanzen

TemozolomidepolydatinGlucosidesCurcuminStilbenes

Autor:innen und Institutionen

  • Institute of Translational Pharmacology, National Research Council of Italy (CNR), 00133 Rome, Italy.
  • National Center for Drug Research and Evaluation, Italian National Institute of Health (ISS), 00161 Rome, Italy.
  • Association for Research on Integrative Oncology Therapies (ARTOI) Foundation, 00165 Rome, Italy.

ORCID-Profile: Annalucia Serafino, Ewa Krystyna Krasnowska, Sabrina Romanò, Alex De Gregorio, Marisa Colone, Maria Luisa Dupuis, Massimo Bonucci, Giampietro Ravagnan, Annarita Stringaro

Förderung

  • ShermanTree Nutraceuticals and MIMIT (Ministry of Enterprise and Made in Italy), Project Invitalia Brevetti+
  • Invitalia Brevetti+
  • European Union—Next Generation EU, within the PNRR project “Rome Technopole—Innovation Ecosystem”

Zitieren

APA

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. International Journal of Molecular Sciences, 25(19), 10572. https://doi.org/10.3390/ijms251910572

Vancouver

Serafino A, Krasnowska EK, Romanò S, De Gregorio A, Colone M, Dupuis ML, et al. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. International Journal of Molecular Sciences. 2024;25(19):10572. doi:10.3390/ijms251910572

BibTeX
@article{Serafino2024,
  author = {Serafino, Annalucia and Krasnowska, Ewa Krystyna and Romanò, Sabrina and De Gregorio, Alex and Colone, Marisa and Dupuis, Maria Luisa and Bonucci, Massimo and Ravagnan, Giampietro and Stringaro, Annarita and Fuggetta, Maria Pia},
  title = {The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {19},
  pages = {10572},
  doi = {10.3390/ijms251910572}
}
Kostenlos starten →